Prospective registry study of efficacy and safety on post marketing surveillance of Matsudaito for hemostasis of vascular anastomosis - Prospective registry study on post marketing surveillance of Hydrofit

<Efficacy verification> 95.6% of anastomotic sites showed hemostatic effect, and 66.7% of anastomotic sites didn't need additional hemostatic procedure, suggesting excellent hemostatic effect. <Safety verification> 94 patients defects/adverse events (incidence rate:16.3%) were reported. Without specificity on the types and occurrence/severity of the AEs, no AEs considered specific to the product. <Summary> Hydrofit is effective and safe, with no problems with the safety and efficacy in real use.